Biological control of postharvest diseases on fruit: a suitable alternative?

In the present overview we discuss about this situation, expose the state of the art, the main concerns and difficulties to increase their commercial use in postharvest. We postulate than is necessary to show consistent efficacy under commercial conditions but this fact is not enough, because some BCAs with reliable performance are not in the market for a complex combination of legal and economic aspects. In the future, it will be necessary to improve the bridge between researchers and private companies.